ARCT Arcturus Therapeutics Holdings Inc
4,899
$27.26
$0.47
(1.75%)
| Watchers | 4,899 |
| 52-Wk Low | $17.52 |
| 52-Wk High | $43.81 |
| Market Cap | $734.06M |
| Volume | 530,924.00 |
| 52-Wk High | $43.81 |
| 52-Wk Low | $17.52 |
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline ProgressBusiness Wire • 2 days ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within...
Share to Feed
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within...
For the last three days, A.I.dvisor has detected that ARCT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Get Free Report) has been given a consensus rating of "Buy" by the seven research firms that are covering the stock, MarketBeat.com reports. Seven...
For the last three days, A.I.dvisor has detected that ARCT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Related Stocks: ARCT...
For the last three days, A.I.dvisor has detected that ARCT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that ARCT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT Get Free Report) COO Pad Chivukula sold 8,565 shares of Arcturus Therapeutics stock in a transaction on Tuesday, March 19th. The shares were...
Related Stocks: ARCT...